[
    [
        {
            "time": "",
            "original_text": "华东医药：Ellansé?伊妍仕?目前的产能与库存充足",
            "features": {
                "keywords": [
                    "Ellansé",
                    "伊妍仕",
                    "产能",
                    "库存"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：Ellansé?伊妍仕?目前的产能与库存充足",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华东医药：公司目前生产经营状况良好",
            "features": {
                "keywords": [
                    "生产经营",
                    "良好"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：公司目前生产经营状况良好",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华东医药：公司的利拉鲁肽已申报上市并受理",
            "features": {
                "keywords": [
                    "利拉鲁肽",
                    "申报上市",
                    "受理"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：公司的利拉鲁肽已申报上市并受理",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "华东医药：子公司拥有百令片和百令颗粒产品文号，但目前销量较低，合计收入占公司百令产品整体收入不到1%",
            "features": {
                "keywords": [
                    "百令片",
                    "百令颗粒",
                    "销量低",
                    "收入占比小"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：子公司拥有百令片和百令颗粒产品文号，但目前销量较低，合计收入占公司百令产品整体收入不到1%",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业：海外新冠治疗药物有望Q4陆续获批 重点推荐相关CDMO标的",
            "features": {
                "keywords": [
                    "新冠治疗药物",
                    "Q4获批",
                    "CDMO"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业：海外新冠治疗药物有望Q4陆续获批 重点推荐相关CDMO标的",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华东医药：Ellansé?伊妍仕?在荷兰生产，荷兰工厂现有的产能可以满足公司预计的市场需求，目前暂未受到疫情影响",
            "features": {
                "keywords": [
                    "Ellansé",
                    "伊妍仕",
                    "荷兰工厂",
                    "产能",
                    "疫情"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：Ellansé?伊妍仕?在荷兰生产，荷兰工厂现有的产能可以满足公司预计的市场需求，目前暂未受到疫情影响",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "BIOTECH/传统药企中报及研发进展总结：BIOTECH迎来商业化时代 传统药企创新转型加速",
            "features": {
                "keywords": [
                    "BIOTECH",
                    "商业化",
                    "创新转型"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "BIOTECH/传统药企中报及研发进展总结：BIOTECH迎来商业化时代 传统药企创新转型加速",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业资金流入榜：6股净流入资金超亿元",
            "features": {
                "keywords": [
                    "资金流入",
                    "医药生物",
                    "净流入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业资金流入榜：6股净流入资金超亿元",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]